Keystone Folding Box Co. develops Key-Pak Plus
Designed to protect children and empower seniors, it achieves top U.S. safety ratings and meets global accessibility standards.
Designed to protect children and empower seniors, it achieves top U.S. safety ratings and meets global accessibility standards.
AAM analysis shows tactics used by brand drug companies to deny market entry to life-saving lower-cost generic medicines and outlines solutions
More Americans will be able to qualify for catastrophic health coverage based on need, beginning November 1st with the start of open enrollment.
Pharmacists’ unique accessibility and health expertise bridge the gap between public health initiatives and the personal choices people make every day.
The West Coast Health Alliance is a new regional partnership dedicated to preserving scientific integrity in public health.
The Association for Accessible Medicines states that lower-cost drugs saved $3.4 trillion over the past decade but warns that regulatory and pricing pressures threaten the market's long-term viability.
Florida Surgeon General Joseph Ladapo has announced plans to end all state vaccine mandates, including school requirements for measles, polio and other preventable diseases.
Spironolactone Oral Suspension is available in 25 mg/5 mL strength and comes in 118 mL and 473 mL bottle sizes.
CVS Health survey finds more than 60% of consumers say they are likely to get a flu shot this season.
Meijer is spotlighting the importance of the flu vaccine as the cornerstone of respiratory health, while also making it easier than ever to stay up to date on additional critical vaccines.
In her new role, Seitzinger will represent HDA’s healthcare distributor members across multiple Midwestern states.
Trump Administration announces forthcoming changes to ease approval of physician-approved treatments and inform patients up-front of the most appropriate and lowest cost prescription drugs.
Ola Snow set to retire in February after nearly 25 years with Cardinal Health.
He will lead all aspects of biosimilars advocacy, policy, and outreach as well as AAM’s policy development and issues management to improve overall market sustainability and increase access to affordable generic and biosimilar medicines.
"Once ACIP acts on the updated COVID-19 vaccines or states take additional action to authorize pharmacy dispensing prior to ACIP recommendations, we’ll be able to offer the FDA-approved COVID-19 vaccines in the remaining states," the company said.
Evernorth's investment coincides with Shields' establishment as a private standalone company upon its acquisition by Sycamore Partners.